ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of innovative cancer immunotherapy products, announced that Joseph C. Maroon, M.D., Charles J. Link, M.D., Jeffery L. Cleland, Ph.D., and Norman D. Schwartz have joined its Board of Directors.
June 21, 2019
· 6 min read